Skip to content
10-K

Annual Report

G1 THERAPEUTICS, INC.

0001628280-24-007601

← back to feed
Filed
Feb 28, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Feb 23, 2024 52.2M sh
Shares Diluted FY 2023 · Dec 31, 2023 51.73M sh
Shares Diluted FY 2023 · Dec 31, 2022 43.63M sh
Shares Diluted FY 2023 · Dec 31, 2021 41.94M sh
Capex FY 2023 · Dec 31, 2023 $0
Capex FY 2023 · Dec 31, 2022 $506K
Capex FY 2023 · Dec 31, 2021 $0
Operating Cash Flow FY 2023 · Dec 31, 2023 −$38.34M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$128.62M
Operating Cash Flow FY 2023 · Dec 31, 2021 −$132.11M
Cash And Equivalents FY 2023 · Dec 31, 2023 $32.22M
Cash And Equivalents FY 2023 · Dec 31, 2022 $94.59M
Stockholders Equity FY 2023 · Dec 31, 2023 $35.39M
Stockholders Equity FY 2023 · Dec 31, 2022 $68.75M
Stockholders Equity FY 2023 · Dec 31, 2021 $143.54M
Stockholders Equity FY 2023 · Dec 31, 2020 $177.35M
Current Liabilities FY 2023 · Dec 31, 2023 $29.72M
Current Liabilities FY 2023 · Dec 31, 2022 $35.59M
Total Liabilities FY 2023 · Dec 31, 2023 $86.15M
Total Liabilities FY 2023 · Dec 31, 2022 $119.22M
Current Assets FY 2023 · Dec 31, 2023 $114.95M
Current Assets FY 2023 · Dec 31, 2022 $179.5M
Total Assets FY 2023 · Dec 31, 2023 $121.54M
Total Assets FY 2023 · Dec 31, 2022 $187.97M
Eps Diluted FY 2023 · Dec 31, 2023 −$0.93
Eps Diluted FY 2023 · Dec 31, 2022 −$3.38
Eps Diluted FY 2023 · Dec 31, 2021 −$3.54
Eps Basic FY 2023 · Dec 31, 2023 −$0.93
Eps Basic FY 2023 · Dec 31, 2022 −$3.38
Eps Basic FY 2023 · Dec 31, 2021 −$3.54
Sga Expense FY 2023 · Dec 31, 2023 $71.13M
Sga Expense FY 2023 · Dec 31, 2022 $100.42M
Sga Expense FY 2023 · Dec 31, 2021 $95.69M
Rd Expense FY 2023 · Dec 31, 2023 $43.71M
Rd Expense FY 2023 · Dec 31, 2022 $83.32M
Rd Expense FY 2023 · Dec 31, 2021 $76.23M
Net Income FY 2023 · Dec 31, 2023 −$47.97M
Net Income FY 2023 · Dec 31, 2022 −$147.56M
Net Income FY 2023 · Dec 31, 2021 −$148.35M
Operating Income FY 2023 · Dec 31, 2023 −$39.53M
Operating Income FY 2023 · Dec 31, 2022 −$136.18M
Operating Income FY 2023 · Dec 31, 2021 −$142.46M
Revenue FY 2023 · Dec 31, 2023 $82.51M
Revenue FY 2023 · Dec 31, 2022 $51.3M
Revenue FY 2023 · Dec 31, 2021 $31.48M